Estrogen, serotonin, and mood disturbance: Where is the therapeutic bridge?

Biological Psychiatry

Volumn 44, Issue 9, 1998, Pages 798-811

  Joffe, Hadine ^a   Cohen, Lee S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Depression; Estrogen; Serotonin; Women

Indexed keywords

ANTIDEPRESSANT AGENT; ESTROGEN; IMIPRAMINE; SEROTONIN; TRAZODONE;

DEPRESSION; ESTROGEN BLOOD LEVEL; HORMONE PROTEIN COMPLEX; HUMAN; HUMAN CELL; HUMAN TISSUE; MOOD; NEUROMODULATION; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SEROTONIN RELEASE;

ANTIDEPRESSIVE AGENTS; DEPRESSION, POSTPARTUM; DEPRESSIVE DISORDER, MAJOR; ENDOCRINE SYSTEM DISEASES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MENOPAUSE; MENSTRUAL CYCLE; MOOD DISORDERS; PREGNANCY; PREMENSTRUAL SYNDROME; PSYCHOTIC DISORDERS; PUERPERAL DISORDERS; SEROTONIN; SEROTONIN AGENTS;

EID: 0032213226     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00169-3     Document Type: Review

References (125)

1. Agren H., Mefford I.N., Rudorfer M.V., Linnoila M., Potter W.Z. Interacting neurotransmitter systems A non-experimental approach to the 5-HIAA-HVA correlation in human CSF . J Psychiatr Res. 20:1986;175-193.
2. Altman N., Sachar E.J., Gruen P.H., Halpern F.S., Eto S. Reduced plasma LH concentration in postmenopausal depressed women. Psychosom Med. 37:1975;274-276.
3. Amenson C.S., Lewinsohn P.M. An investigation into the observed sex difference in prevalence of unipolar depression. J Abnorm Psychol. 90:1981;1-13.
4. Amsterdam J.D., Winokur A., Lucki I., Snyder P. Neuroendocrine regulation in depressed postmenopausal women and healthy subjects. Acta Psychiatr Scand. 67:1983;43-49.
5. Avis N.E., Brambilla D., McKinlay S.M., Vass K. A longitudinal analysis of the association between menopause and depression Results from the Massachusetts Women's Health Study . Ann Epidemiol. 4:1994;214-220.
6. Aylward M. Plasma tryptophan levels and mental depression in post-menopausal subjects Effects of oral piperazine oestrone sulfate . Int Res Commun Syst. 1:1973;30.
7. 1 receptors in brain. J Neurosci. 2:1982;199-205.
8. Biegon A., Bercovitz H., Samuel D. Serotonin receptor concentration during the estrous cycle of the rat. Brain Res. 187:1980;221-225.
9. Birnbaum C., Cohen L. The psychiatric evaluation and treatment of premenstrual dysphoric disorder. Pollack M.H., Otto M.W., Rosenbaum J.F. Challenges in Clinical Practice. 1996;408-431 The Guilford Press, New York.
10. Biver F., Lotstra F., Monclus M., Wikler D., Damhaut P., Mendlewicz J., et al. Sex difference in 5HT2 receptor in the living human brain. Neurosci Lett. 204:1996;25-28.
11. Brambilla F., Maggioni M., Ferrari E., Scarone S., Catalono M. Tonic and dynamic gonadotropin secretion in depressive and normothymic phases of affective disorders. Psychiatry Res. 32:1990;229-239.
12. Brincat M., Studd J.W.W., O'Dowd T., Magos A., Cardozo L.D., Wardle P.J., et al. Subcutaneous hormone implants for the control of climacteric symptoms. Lancet. 1:1984;16-18.
13. Brown C.S., Ling F.W., Andersen R.N., Farmer R.B., Arheart K.L. Efficacy of depot leuprolide in premenstrual syndrome Effect of symptom severity and type in a controlled trial . Obstet Gynecol. 84:1994;779-786.
14. Campbell S., Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol. 4:1977;31-47.
15. Carlsson M., Carlsson A. A regional study of sex differences in rat brain serotonin. Prog Neuropsychopharmacol Biol Psychiatry. 12:1988;53-61.
16. Chouinard G., Steinberg S., Steiner W. Estrogen-progesterone combination Another mood stabilizer? Am J Psychiatry. 144:1987;826.
17. Cohen L, Morabito C, Collins M, Viguera A (1998): Venlafaxine in the treatment of postpartum depression. Accepted for presentation at the American Psychiatric Association Annual Meeting, Toronto, Canada.
18. Cookson J.C. The neuroendocrinology of mania. J Affect Disord. 8:1985;233-241.
19. Coope J. Is oestrogen therapy effective in the treatment of menopausal depression? J R Coll Gen Pract. 31:1981;134-140.
20. Coryell W., Endicott J., Keller M.B. Predictors of relapse into major depressive disorder in a nonclinical population. Am J Psychiatry. 148:1991;1353-1358.
21. Coryell W., Endicott J., Keller M. Major depression in a nonclinical sample Demographic and clinical risk factors for first onset . Arch Gen Psychiatry. 49:1992;117-125.
22. Dean C., Williams R.J., Brockington I.F. Is puerperal psychosis the same as bipolar manic-depressive disorder? A family study. Psychol Med. 19:1989;637-647.
23. Dennerstein L., Burrows G.D., Hyman G., Sharpe K. Hormone therapy and affect. Maturitas. 1:1979;247-259.
24. Ditkoff E.C., Crary W.G., Cristo M., Lobo R.A. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol. 78:1991;991-995.
25. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry. 54:1997;597-606.
26. Easterbrook C.C. Organo-therapeutic in mental disease. Br Med J. 2:1900;813-823.
27. Endicott J. The menstrual cycle and mood disorders. J Affect Disord. 29:1993;193-200.
28. Eriksson E., Hedberg M.A., Andersch B., Sundblad C. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology. 12:1995;167-176.
29. Ernst C., Angst J. The Zurich Study XII Sex differences in depression: Evidence from longitudinal epidemiological data . Eur Arch Psychiatry Clin Neurosci. 241:1992;222-230.
30. Finegan J., Bartleman B., Wong P.Y. A window for the study of prenatal sex hormone influences on postnatal development. J Genet Psychol. 150:1988;101-112.
31. Fink G., Sumner B.E.H., Rosie R., Grace O., Quinn J.P. Estrogen control of central neurotransmission Effect on mood, mental state, and memory . Cell Mol Neurobiol. 16:1996;325-344.
32. Fludder J.M., Tonge S.R. Variations in the concentrations of monoamines and their metabolites in eight regions of rat brain during the oestrus cycle A basis for interactions between hormones and psychotropic drugs . J Pharm Pharmacol. 27:1975;39P.
33. Frank E., Kupfer D.J., Jacob M., Blumenthal S.J., Jarrett D.B. Pregnancy-related affective episodes among women with recurrent depression. Am J Psychiatry. 144:1987;288-293.
34. Frank E., Carpenter L.L., Kupfer D.J. Sex differences in recurrent depression Are there any that are significant? Am J Psychiatry. 145:1988;41-45.
35. Frank E., Kupfer D.J., Perel J.M., Cornes C., Jarrett D.B., Mallinger A.G., et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 47:1990;1093-1099.
36. Furuhjelm M., Karlgren E., Carlström K. The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women. Acta Obstet Gynecol Scand. 63:1984;655-661.
37. Gregoire A.J.P., Kumar R., Everitt B., Henderson A.F., Studd J.W.W. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 347:1996;930-933.
38. Guicheney P., Léger D., Barrat J., Trévoux R., De Ligniéres B., Roques P., et al. Platelet serotonin content and plasma tryptophan in peri- and postmenopausal women Variations with plasma oestrogen levels and depressive symptoms . Eur J Clin Invest. 18:1988;297-304.
39. Haleem D.J., Kennett G.A., Curzon G. Hippocampal 5-hydroxy-tryptamine synthesis is greater in female rats than in males and more decreased by the 5-HT1A agonist 8-OH-DPAT. J Neural Transm Gen Sect. 79:1990;93-101.
40. Hammarbäck S., Bäckström T. Induced anovulation as a treatment of premenstrual tension syndrome A double-blind cross-over study with GnRH-agonist versus placebo . Acta Obstet Gynecol Scand. 67:1988;159-166.
41. Hammarbäck S., Bäckström T., Holt J., von Schoultz B., Lyrenäs S. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progesteron postmenopausal replacement therapy. Acta Obstet Gynecol Scand. 64:1985;393-397.
42. Holsboer F., Benkert O., Demisch L. Changes in MAO activity during estrogen treatment of females with endogenous depression. Mod Probl Pharmacopsychiatry. 19:1983;321-326.
43. Holst J., Bäckström T., Hammarbäck S., von Schoultz B. Progesteron addition during oestrogen replacement therapy - Effects on vasomotor symptoms and mood. Maturitas. 11:1989;13-20.
44. Iatrakis G., Haronis N., Sakellaropoulos G., Kourkoubas A., Gallos M. Psychosomatic symptoms of postmenopausal women with or without hormonal treatment. Psychother Psychosom. 46:1986;116-121.
45. Jaszmann L., van Lith N.D., Zaat J.C.A. The perimenopausal symptoms The statistical analysis of a survey . Med Gynecol Sociol. 4:1969;268-277.
46. Joffe R.T., Levitt A.J., Sokolov S.T.H. Augmentation strategies Focus on anxiolytics . J Clin Psychiatry. 57:(suppl 7):1996;25-33.
47. Kendall D.A., Stancel G.M., Enna S.J. Imipramine Effect of ovarian steroids on modifications in serotonin receptor binding . Science. 211:1981;1183-1185.
48. Kendall D.A., Stancel G.M., Enna S.J. The influence of sex hormones on antidepressant-induced alterations in neurotransmitter receptor binding. J Neurosci. 2:1982;354-360.
49. Kendell R.E., Chalmers J.C., Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry. 150:1987;662-673.
50. Kessler R.C., McGonagle K.A., Swartz M., Blazer D.G., Nelson C.B. Sex and depression in the National Comorbidity Survey I Lifetime prevalence, chronicity and recurrence . J Affect Disord. 29:1993;85-96.
51. Klaiber E.L., Broverman D.M., Vogel W., Kobayashi Y. Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry. 36:1979;550-554.
52. Kukopulos A., Reginaldi D., Laddomada P., Floris G., Serra G., Tondo L. Course of the manic-depressive cycle and changes caused by treatments. Pharmacopsychiatry. 13:1980;156-167.
53. Kumar R., Robson K.M. A prospective study of emotional disorders in childbearing women. Br J Psychiatry. 144:1984;35-47.
54. Lasser R.A., Baldessarini R.J. Thyroid hormones in depressive disorders A reappraisal of clinical utility . Harvard Rev Psychiatry. 4:1997;291-305.
55. Leibenluft E. Women with bipolar illness Clinical and research issues . Am J Psychiatry. 153:1996;163-173.
56. Lewinsohn P.M., Zeiss A.M., Duncan E.M. Probability of relapse after recovery from an episode of depression. J Abnorm Psychol. 98:1989;107-116.
57. Limouzin-Lamothe M., Mairon N., Joyce C.R.B., LeGal M. Quality of life after the menopause Influence of hormonal replacement therapy . Am J Obstet Gynecol. 170:1994;618-624.
58. Mamounas L.A., Blue M.E., Siuciak J.A., Altar C.A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci. 15:1995;7929-7939.
59. Mann J.J., Stanley M., McBride P.A., McEwen B.S. Increased serotonin 2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry. 43:1986;954-959.
60. McDermott J.F. Jr, Robillard A.B., Char W.F., Hsu J., Tseng W.S., Ashton G.C. Reexamining the concept of adolescence Differences between adolescent boys and girls in the context of their families . Am J Psychiatry. 140:1983;1318-1322.
61. McEwen B.S. Nongenomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci. 12:1991;141-147.
62. McEwen BS, Alves SE, Bulloch K, Weiland NG (1997): Ovarian steroids and the brain: Implications for cognition and aging. Neurology 48(suppl 7):S8-S15.
63. McGrath P.J., Stewart J.W., Nunes E.V., Ocepek-Welikson K., Rabkin J.G., Quitkin F.M., et al. A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression. Am J Psychiatry. 150:1993;118-123.
64. McKinlay J.B., McKinlay S.M., Brambilla D. The relative contributions of endocrine changes and social circumstances to depression in mid-aged women. J Health Soc Behav. 28:1987;345-363.
65. McQueen J.K., Wilson H., Dow R.C., Fink G. Oestradiol-17β increases serotonin transporter (SERT) binding sites and SERT mRNA expression in discrete regions of female rat brain. J Physiol. 495:1996;114P.
66. Montgomery J.C., Brinct M., Tapp A., Appleby L., Versi E., Fenwick P.B.C., et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet. 1:1987;297-299.
67. Morris N.M., Udry F.R. Contraceptive pills and the day to day feelings of well-being. Am J Obstet Gynecol. 113:1972;763-765.
68. Muse K.N. Hormonal manipulation in the treatment of premenstrual syndrome. Clin Obstet Gynecol. 35:1992;658-666.
69. Muse K.N., Cetel N.S., Futterman L.A., Yen S.S.C. The premenstrual syndrome Effects of "medical ovariectomy" N Engl J Med. 311:1984;345-349.
70. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatment. J Neurosci. 15:1995;7439-7547.
71. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element-binding protein (CREB) in rat hippocampus. J Neurosci. 16:1996;2365-2372.
72. Nierenberg A.A., McColl R.D. Management options for refractory depression. Am J Med. 101:1996;45S-52S.
73. Nishizawa S., Benkelfat C., Young S.N., Leyton M., Mzengeza S., deMontignuy C., et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA. 94:1997;5308-5313.
74. Nolen-Hoeksema S. Sex differences in unipolar depression Evidence and theory . Psychol Bull. 101:1987;259-282.
75. Nott P.N., Franklin M., Armitage C., Gelder M.G. Hormonal changes and mood in the puerperium. Br J Psychiatry. 128:1976;379-383.
76. O'Hara M.W. Social support, life events and depression during pregnancy and the puerperium. Arch Gen Psychiatry. 43:1986;569-573.
77. O'Hara M.W., Neunaber D.J., Zekoski E.M. Prospective study of postpartum depression Prevalence, course, and predictive factors . J Abnorm Psychol. 93:1984;158-171.
78. O'Hara M.W., Zekoski E.M., Phillips L.H., Wright E.J. A controlled prospective study of postpartum mood disorders Comparison of childbearing and nonchildbearing women . J Abnorm Psychol. 99:1990;3-15.
79. O'Malley B.W., Means A.R. Female steroid hormone and target cell nuclei. Science. 183:1974;610-620.
80. Oppenheim G. A case report of rapid mood cycling with estrogen Implications for therapy . J Clin Psychiatry. 45:1984;34-35.
81. Palinkas L.A., Barrett-Connor E. Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol. 80:1992;30-36.
82. Pearlstein T.B., Stone A.B., Lund S.A., Sheft H., Zlotnick C., Brown W.A. Comparison of fluoxetine, buproprion, and placebo in the treatment of premenstrual dysphoric disorder. J Clin Psychopharmacol. 17:1997;261-266.
83. Prange A.J. Estrogen may well affect response to antidepressants. JAMA. 219:1972;143-144.
84. Price W.A., Giannini A.J. Antidepressant effects of estrogen [letter]. J Clin Psychiatry. 46:1985;506.
85. Reich T., Winokur G. Postpartum psychosis in patients with manic depressive disease. J Nerv Ment Dis. 151:1970;60-68.
86. Rosencrans J.A. Differences in brain area 5-hydroxy-tryptamine turnover and rearing behavior in rats and mice of both sexes. Eur J Pharmacol. 9:1970;379-382.
87. Rubinow D.R., Schmidt P.J. Androgens, brain, and behavior. Am J Psychiatry. 153:1996;974-984.
88. Rubinow D.R., Hoban M.C., Grover G.N., Galloway D.S., Roy-Byrne P., Andersen R., et al. Changes in plasma hormones across the menstrual cycle in patients with menstrually-related mood disorders and in control subjects. Am J Obstet Gynecol. 158:1988;5-11.
89. Rubinow D.R., Schmidt P.J., Roca C.A. Estrogen-serotonin interactions Implications for affective regulation . Biol Psychiatry. 44:1998;839-850.
90. Sachar E.J., Schalch D.S., Reichlin S. Plasma gonadotrophins in depressive illness A preliminary report . Williams T.A., Katz M.M., Shield J.A. Jr. Recent Advances in the Psychobiology of the Depressive Illnesses. 1972;229-233 US Department of Health and Welfare, Washington, DC.
91. Sargeant J.K., Bruce M.L., Florio L.P., Weissman M.M. Factors associated with one-year outcome of major depression in the community. Arch Gen Psychiatry. 47:1990;519-526.
92. Schmidt P.J., Rubinow D.R. Menopause-related affective disorders A justification for further study . Am J Psychiatry. 148:1994;844-852.
93. Schmidt P.J., Roca C.A., Bloch M., Rubinow D.R. The perimenopause and affective disorders. Sem Reprod Endocrinol. 15:1997;91-100.
94. Schmidt P.J., Neiman L.K., Danaeau M.A., Adams L.F., Rubinow D.R. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 338:1998;209-216.
95. Schneider M.A., Brotherton P.L., Hailes J. The effect of exogenous oestrogens on depression in menopausal women. Med J Aust. 2:1977;162-163.
96. Schneider L.S., Small G.W., Hamilton S.H., Bystritsky A., Nemeroff C.B., Meyers B.S. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Am J Geriatr Psychiatry. 5:1997;97-106.
97. Seeman M.V. Psychopathology in women and men Focus on female hormones . Am J Psychiatry. 154:1997;1641-1647.
98. Shapira B., Oppenheim G., Zohar J. Lack of efficacy of estrogen supplementation to imipramine in resistant female depressive. Biol Psychiatry. 20:1985;576-579.
99. Sherwin B.B. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab. 72:1991;336-343.
100. Sherwin B.B., Gelfand M.M. Sex steroids and affect in the surgical menopause A double-blind, cross-over study . Psychoneuroendocrinology. 10:1985;325-335.
101. Sichel D.A., Cohen L.S., Robertson L.M., Ruttenberg A., Rosenbaum J.F. Prophylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry. 38:1995;814-818.
102. Simpkins J.W., Green P.S., Gridley K.E., Singh M., de Fiebre N.E.C., Rajakumar G. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. Am J Med. 103:1997;19S-25S.
103. Simpson H.B., Nee J.C., Endicott J. First-episode major depression. Arch Gen Psychiatry. 54:1997;633-639.
104. Singh M., Meyer E.M., Simpkins J.W. The effects of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal regions of the female Sprague-Dawley rat. Endocrinology. 136:1995;2320-2324.
105. Sohrabji F., Greene L.A., Miranda R.C., Toran-Allerand C.D. Reciprocal regulation of estrogen and NGF receptors by their ligands in PC12 cells. J Neurobiol. 25:1994;974-988.
106. Sohrabji F., Miranda R.C., Torand-Allerand C.D. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci. 14:1994;459-471.
107. Stahl S.M. Essential Psychopharmacology. 1996;Cambridge University Press, New York.
108. Steiner M., Steinberg S., Stewart D., Carter D., Berger C., Reid R., et al. Fluoxetine in the treatment of premenstrual syndrome. N Engl J Med. 332:1995;1529-1534.
109. Stewart D.E. Prophylactic lithium in postpartum affective psychosis. J Nerv Ment Dis. 176:1988;485-489.
110. Stowe Z.N., Casarella J., Landry J. Sertraline in the treatment of women with postpartum major depression. Depression. 3:1995;49-55.
111. Strickler R.C., Borth R., Cecutti A., Cookson B.A., Harper J.A., Potvin R., et al. The role of oestrogen replacement in the climacteric syndrome. Psychol Med. 7:1977;631-639.
112. Sumner B.E.H., Fink G. Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain. Mol Cell Neurosci. 4:1993;83-92.
113. 2A receptors in cerebral cortex and nucleus accumbens in the famale rat. J Steroid Biochem Mol Biol. 54:1995;15-20.
114. Thomson J. Double blind study on the effect of oestrogen on sleep, anxiety and depression in perimenopausal women Preliminary results . Proc R Soc Med. 69:1976;17-18.
115. Uphouse L., Williams J., Eckols K., Sierra V. Cortical changes in serotonin receptors during the female rat estrous cycle. Brain Res. 381:1986;376-381.
116. Vitali M.L., Parisi M.N., Chiocchio S.R., Tramezzani J.H. Median eminence serotonin involved in the proestrus gonadotropin release. Neuroendocrinology. 39:1984;136-141.
117. Vogel W., Klaiber E.L., Broverman D.M. Roles of the gonadal steroid hormones in psychiatric depression in men and women. Prog Neuropsychopharmacol. 2:1978;487-503.
118. Weissman M.M., Leaf P.J., Tischler G.L., Blazer D.G., Karno M., Bruce M.L., et al. Affective disorders in five United States communities. Psychol Med. 18:1988;141-153.
119. Wieck A., Kumar R., Hirst A.D., Marks M.N., Campbell I.C., Checkley S.A. Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth. Br Med J. 303:1991;613-616.
120. Wiklund I, Holst J, Karlberg J, Mattsson L-Å, Samsioe G, Sandin K, et al (1992): A new methodological approach to the evaluation of quality of life in postmenopausal women. Maturitas 14:211-224.
121. Winokur A., Amsterdam J., Caroff S., Snyder P.J., Brunswick D. Variability of hormonal responses to a series of neuroendocrine challenges in depressed patients. Am J Psychiatry. 139:1982;39-44.
122. Winokur G., Coryell Keller M., Endicott J., Akiskal H. A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch Gen Psychiatry. 50:1993;457-465.
123. Wisner K.L., Wheeler S.B. Prevention of recurrent postpartum major depression. Hosp Community Psychiatry. 45:1994;1191-1196.
124. Young R.C., Moline M., Kleyman F. Hormone replacement therapy and late-life mania. Am J Geriatr Psychiatry. 5:1997;179-181.
125. Zohar J., Shapira B., Oppenheim G., Ayd F.J., Belmaker R.H. Addition of estrogen to imipramine in female-resistant depressives. Psychopharmacol Bull. 21:1985;705-706.